These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30428394)

  • 1. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
    Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
    Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights in galectin-1-glycan recognition: Relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties.
    Porciúncula-González C; Cagnoni AJ; Fontana C; Mariño KV; Saenz-Méndez P; Giacomini C; Irazoqui G
    Bioorg Med Chem; 2021 Aug; 44():116309. PubMed ID: 34293617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
    Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
    Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of stable and selective inhibitors of human galectins-1 and -3.
    Giguère D; Bonin MA; Cloutier P; Patnam R; St-Pierre C; Sato S; Roy R
    Bioorg Med Chem; 2008 Aug; 16(16):7811-23. PubMed ID: 18674915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design and Synthesis of Methyl-β-d-galactomalonyl Phenyl Esters as Potent Galectin-8
    Patel B; Kishor C; Houston TA; Shatz-Azoulay H; Zick Y; Vinik Y; Blanchard H
    J Med Chem; 2020 Oct; 63(20):11573-11584. PubMed ID: 32809817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
    Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
    Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
    Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
    Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
    Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
    Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of galectins with small molecules.
    Oberg CT; Leffler H; Nilsson UJ
    Chimia (Aarau); 2011; 65(1-2):18-23. PubMed ID: 21469439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.
    Giguère D; Sato S; St-Pierre C; Sirois S; Roy R
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1668-72. PubMed ID: 16403629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.
    Téllez-Sanz R; García-Fuentes L; Vargas-Berenguel A
    Curr Med Chem; 2013; 20(24):2979-90. PubMed ID: 23834183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
    Oberg CT; Blanchard H; Leffler H; Nilsson UJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactulose as a novel template for anticancer drug development targeting galectins.
    Kishor C; Ross RL; Blanchard H
    Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.
    Masuyer G; Jabeen T; Öberg CT; Leffler H; Nilsson UJ; Acharya KR
    FEBS J; 2012 Jan; 279(2):193-202. PubMed ID: 22059385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.
    Hirabayashi J; Hashidate T; Arata Y; Nishi N; Nakamura T; Hirashima M; Urashima T; Oka T; Futai M; Muller WE; Yagi F; Kasai K
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):232-54. PubMed ID: 12223272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.
    Oberg CT; Leffler H; Nilsson UJ
    J Med Chem; 2008 Apr; 51(7):2297-301. PubMed ID: 18318467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features for α-galactomannan binding to galectin-1.
    Miller MC; Klyosov AA; Mayo KH
    Glycobiology; 2012 Apr; 22(4):543-51. PubMed ID: 22156919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic synthesis of 2-aminoethyl β-D-galactopyranoside catalyzed by Aspergillus oryzae β-galactosidase.
    Porciúncula González C; Castilla A; Garófalo L; Soule S; Irazoqui G; Giacomini C
    Carbohydr Res; 2013 Mar; 368():104-10. PubMed ID: 23357285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development.
    Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C
    Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.